Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
FLXN | Flexion Therapeutics Inc | Versant Venture Capital III, L.P. | 10% Owner | Jun 08, 2016 | Buy | $14.00 | 714,285 | 9,999,990 | 3,511,670 | Jun 10, 2016, 09:16 PM | |
PZRX | PHASERX, INC. | Versant Venture Capital III, L.P. | 10% Owner | May 23, 2016 | Buy | $3.50 | 853,006 | 2,984,950 | 1,931,094 | May 24, 2016, 05:05 PM | |
PZRX | PHASERX, INC. | Versant Venture Capital III, L.P. | 10% Owner | May 23, 2016 | Sale | $3.50 | 5,038 | 17,630 | 11,408 | May 24, 2016, 05:05 PM | |
OCUL | OCULAR THERAPEUTIX, INC | Versant Venture Capital III, L.P. | 10% Owner | Jun 15, 2015 | Sale | $22.00 | 1,878 | 41,316 | 13,007 | Jun 15, 2015, 05:51 PM | |
OCUL | OCULAR THERAPEUTIX, INC | Versant Venture Capital III, L.P. | 10% Owner | Jun 15, 2015 | Sale | $22.00 | 318,122 | 6,998,684 | 2,202,377 | Jun 15, 2015, 05:51 PM | |
OCUL | OCULAR THERAPEUTIX, INC | Versant Venture Capital III, L.P. | 10% Owner | Jun 10, 2015 | Sale | $22.00 | 848,988 | 18,677,736 | 2,520,499 | Jun 11, 2015, 05:24 PM | |
OCUL | OCULAR THERAPEUTIX, INC | Versant Venture Capital III, L.P. | 10% Owner | Jun 10, 2015 | Sale | $22.00 | 5,012 | 110,264 | 14,885 | Jun 11, 2015, 05:24 PM | |
OPGN,OPGNW | OPGEN INC | Versant Venture Capital III, L.P. | 10% Owner | May 08, 2015 | Buy | $6.00 | 2,426 | 14,556 | 2,853 | May 12, 2015, 06:54 PM | |
OPGN,OPGNW | OPGEN INC | Versant Venture Capital III, L.P. | 10% Owner | May 08, 2015 | Buy | $6.00 | 410,906 | 2,465,436 | 483,072 | May 12, 2015, 06:54 PM | |
FLXN | Flexion Therapeutics Inc | Versant Venture Capital III, L.P. | Director | Sep 10, 2014 | Option Exercise | $17.61 | 2,250 | 39,623 | 2,250 | Sep 12, 2014, 09:00 PM | |
FLXN | Flexion Therapeutics Inc | Versant Venture Capital III, L.P. | Director | Sep 10, 2014 | Option Exercise | $17.61 | 2,250 | 39,623 | 2,250 | Sep 12, 2014, 08:13 PM | |
IMDZ | Immune Design Corp. | Versant Venture Capital III, L.P. | 10% Owner | Jul 29, 2014 | Sale | $12.00 | 441,667 | 5,300,004 | 2,208,210 | Jul 31, 2014, 05:53 PM | |
FLXN | Flexion Therapeutics Inc | Versant Venture Capital III, L.P. | 10% Owner | Feb 18, 2014 | Buy | $13.00 | 305,886 | 3,976,518 | 3,205,001 | Feb 20, 2014, 03:01 PM | |
FLXN | Flexion Therapeutics Inc | Versant Venture Capital III, L.P. | 10% Owner | Feb 18, 2014 | Buy | $13.00 | 1,806 | 23,478 | 3,206,807 | Feb 20, 2014, 03:01 PM | |
TSRX | Trius Therapeutics Inc | Versant Venture Capital III, L.P. | 10% Owner | Aug 06, 2010 | Option Exercise | $4.72 | 1,659,025 | 7,833,538 | 3,235,839 | Aug 10, 2010, 02:12 PM |